Therefore, a binary repeated measurement analysis was done, indicating an increase in the proportion of ER-negative tumours between the first and the CBC in tamoxifen-treated patients compared to patients without previous tamoxifen treatment (P=0.012). This evidence concerns the gene ESR1 and neoplasm.